Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BlueOcean NutraSciences Inc. was a Canadian nutraceutical company that specialized in the development and commercialization of high-value specialty oils, primarily focused on shrimp oil-based Omega-3 products. The company leveraged its proprietary CO2 infusion technology to produce supplements such as Pure Polar and AstaSante, which were marketed for their superior bioavailability and high astaxanthin content compared to traditional fish oils. These products were designed to support cardiovascular, joint, and overall metabolic health through the enhanced delivery of essential fatty acids. In July 2018, the company underwent a strategic pivot and rebranded as CO2 GRO Inc. to focus exclusively on its CO2 gas infusion technology for increasing plant yields in the commercial greenhouse industry. Consequently, its original nutraceutical business was phased out in favor of agricultural technology solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BlueOcean NutraSciences.